Covid-19 vaccine
Qatar Airways Cargo has transported more than 600 million doses of COVID-19 vaccines over the course of the Coronavirus pandemic to date, reveals Qatar Airways Annual Report 2021-2022. Qatar Airways Cargo was able to fulfil its commitment to the U..
The State of Qatar stressed that the Coronavirus (Covid-19) pandemic represented the greatest health challenge facing humanity for decades, and that there is still a need to make more efforts to promote equality in the availability of vaccines and en..
The Ministry of Public Health has approved the use of a fourth vaccine dose of Pfizer/BioNTech and Moderna COVID-19 vaccines for individuals at high-risk of severe infection. The fourth dose is only applicable to individuals 60 years of age ..
Moderna Inc (MRNA.O) said on Wednesday it will ask regulators to authorize its COVID-19 vaccine in children younger than 6 years old based on data showing it generated a similar immune response to adults in its clinical trial. The Omicro..
The State of Qatar has affirmed its firm humanitarian and moral position that all must be fairly given COVID-19 vaccines, stressing that overcoming the pandemic requires solidarity and a sense of shared responsibility by all to find a solution. Th..
The UK has approved a fifth Covid-19 vaccine, developed by US company Novavax, which offers up to 89% protection against Covid illness. The Medicines and Healthcare products Regulatory Agency has said it is safe as a first and second dose in adult..
U.S. regulators are considering the first COVID-19 vaccine for children under the age of 5, the only age group not yet eligible for the shots, after Pfizer Inc (PFE.N) and BioNTech SE began the regulatory approval pr...
The Ministry of Public Health has approved the administration of Pfizer-BioNTech COVID-19 vaccines for children aged 5 to 11 years. The decision is in line with the recent studies that demonstrate the safety and efficacy of the Pfizer-BioNTe..
Moderna Inc's (MRNA.O) vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel sa..
.jpg)
.jpg)
.jpg)
.png)
.jpg)
